If they are looking for VC investment that would mean partner discussions aren't as mature as they would lead us to believe. We are ill equipped to take anything into PIII. That would also mean that big pharma wasn't sold on the efficacy of BAVI. Just my opinion. The stock price is just not acting as anything good is on the horizon. Hope I am wrong but I am getting a bad feeling